ANNA MALOVANNAYA to Mutation
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Mutation.
Connection Strength
0.134
-
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations. Blood Cancer J. 2025 03 15; 15(1):40.
Score: 0.085
-
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 10 02; 83(19):3237-3251.
Score: 0.019
-
Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy. Nat Commun. 2022 01 10; 13(1):134.
Score: 0.017
-
MiR-146a wild-type 3' sequence identity is dispensable for proper innate immune function in vivo. Life Sci Alliance. 2019 02; 2(1).
Score: 0.014